Evidence map›Paper›PMID 31396200›Full record

ReviewFrontiers in microbiology2019

Biosynthesis and Bioactivity of Prodiginine Analogs in Marine Bacteria,

Francis E Sakai-Kawada, Courtney G Ip, Kehau A Hagiwara, Jonathan D Awaya

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 61 citations in OpenAlex.

  1. High-level prodigiosin production inSynthetic and systems biotechnology · 2026
    Article
  2. Article
  3. Comparative genome analysis and secondary biosynthetic potential of the Streptomyces microflavus strains isolated from high altitude.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. β-Lactams from the Ocean.Marine drugs · 2023
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Francis E Sakai-KawadaDepartment of Molecular Biosciences and Bioengineering, University of Hawai´i at Mānoa, Honolulu, HI, United States.
Courtney G IpDepartment of Biology, University of Hawai´i at Hilo, Hilo, HI, United States.
Kehau A HagiwaraInstitute of Marine and Environmental Technology, University of Maryland, Baltimore, Baltimore, MD, United States.
Jonathan D AwayaDepartment of Molecular Biosciences and Bioengineering, University of Hawai´i at Mānoa, Honolulu, HI, United States.
University of Hawaii at Hilo · USUniversity of Hawaiʻi at Mānoa · USUniversity of Maryland, Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Prodiginine family consists of primarily red-pigmented tripyrrole secondary metabolites that were first characterized in the Gram-negative bacterial species

Indexed as

marine bacteriapigmentsprodigininesprodigiosinPseudoalteromonassecondary metabolites

Identifiers

PMID31396200
PMCPMC6667630
OpenAlexW2961007332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.